Magic mushroom therapy targets stomach pain in early trial

NCT ID NCT06760533

Not yet recruiting Symptom relief Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Mar 16, 2026 · Last updated Jun 16, 2026 · Updated 18 times

Summary

This early study tests whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy can help people with severe irritable bowel syndrome (IBS). Ten adults with hard-to-treat IBS will receive either a high dose of psilocybin or a placebo (niacin) during a guided session, plus several therapy meetings before and after. The goal is to see if this approach is feasible and reduces abdominal pain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IBS - IRRITABLE BOWEL SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

NYU Langone Health

New York, New York, 10016, United States

Conditions

The condition(s) this trial relates to.

irritable bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IBS - IRRITABLE BOWEL SYNDROME IBS - IRRITABLE BOWEL SYNDROME